Cargando…

KRAS Mutations in Colorectal Cancer: Relationship With Clinicopathological Characteristics and Impact on Clinical Outcomes in Saudi Arabia

Background Few studies have addressed the prevalence and prognostic impacts of KRAS mutations in Saudi patients with colorectal cancer (CRC). The present study aimed to address the prevalence of KRAS mutations and evaluate their impact on clinical outcomes (if any) among Saudi patients. Methods This...

Descripción completa

Detalles Bibliográficos
Autores principales: Alghamdi, Mohammed, Alabdullatif, Nujud, Al-Rashoud, Ajeed, Alotaibi, Joud, Alhussaini, Nouf, Elsirawani, Sedra, Somily, Haneen, Alkhudair, Norah, AlOtaiby, Maram, Ahamed, Shaik S, Abd El-Aziz, Nashwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053648/
https://www.ncbi.nlm.nih.gov/pubmed/35505757
http://dx.doi.org/10.7759/cureus.23656
_version_ 1784697026908258304
author Alghamdi, Mohammed
Alabdullatif, Nujud
Al-Rashoud, Ajeed
Alotaibi, Joud
Alhussaini, Nouf
Elsirawani, Sedra
Somily, Haneen
Alkhudair, Norah
AlOtaiby, Maram
Ahamed, Shaik S
Abd El-Aziz, Nashwa
author_facet Alghamdi, Mohammed
Alabdullatif, Nujud
Al-Rashoud, Ajeed
Alotaibi, Joud
Alhussaini, Nouf
Elsirawani, Sedra
Somily, Haneen
Alkhudair, Norah
AlOtaiby, Maram
Ahamed, Shaik S
Abd El-Aziz, Nashwa
author_sort Alghamdi, Mohammed
collection PubMed
description Background Few studies have addressed the prevalence and prognostic impacts of KRAS mutations in Saudi patients with colorectal cancer (CRC). The present study aimed to address the prevalence of KRAS mutations and evaluate their impact on clinical outcomes (if any) among Saudi patients. Methods This retrospective cohort study was conducted at King Saud University Medical Centre (KSUMC), Saudi Arabia. All medical records of biopsy-proven CRC patients between 2015 and 2021 were reviewed. Statistical analysis was carried out to address the associations between KRAS mutations and the clinicopathological patients’ variables and survival. Results KRAS mutations were found in 97/194 (50%) CRC patients. In comparison to wild type KRAS tumors, KRAS- mutated ones had shown a trend toward right-sided tumors (30% and 4.3% vs 16% and 1.1%, p-value = 0.032, respectively) and peritoneal metastases (34% vs 19%, p-value = 0.014). Older age at diagnosis, gender, tumor grade, microsatellite instability (MSI), tumor stage (T), and the presence of distant metastasis were independent prognostic factors for poor overall survival (OS). There was no significant association between KRAS mutations and the hazard of mortality (HR: 0.653, 95% CI 0.873-1.134, p = 0.131). For progression-free survival (PFS), older age at presentation, MSI, tumor nodal stage (N), the presence of liver and lung metastasis, and recurrence were poor prognostic factors for PFS. There was no significant relation between KRAS mutations and PFS (HR ratio: 0.756, 95% CI 0.229-2.497, p = 0.646). Conclusions The prevalence of KRAS mutations in CRC patients was similar to that observed in previous studies of Saudi patients. KRAS mutations showed a trend toward right-sided tumors and peritoneal metastases. Survival was significantly related to different clinicopathologic variables of the study cohort but was not affected by the KRAS mutational status.
format Online
Article
Text
id pubmed-9053648
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-90536482022-05-02 KRAS Mutations in Colorectal Cancer: Relationship With Clinicopathological Characteristics and Impact on Clinical Outcomes in Saudi Arabia Alghamdi, Mohammed Alabdullatif, Nujud Al-Rashoud, Ajeed Alotaibi, Joud Alhussaini, Nouf Elsirawani, Sedra Somily, Haneen Alkhudair, Norah AlOtaiby, Maram Ahamed, Shaik S Abd El-Aziz, Nashwa Cureus Internal Medicine Background Few studies have addressed the prevalence and prognostic impacts of KRAS mutations in Saudi patients with colorectal cancer (CRC). The present study aimed to address the prevalence of KRAS mutations and evaluate their impact on clinical outcomes (if any) among Saudi patients. Methods This retrospective cohort study was conducted at King Saud University Medical Centre (KSUMC), Saudi Arabia. All medical records of biopsy-proven CRC patients between 2015 and 2021 were reviewed. Statistical analysis was carried out to address the associations between KRAS mutations and the clinicopathological patients’ variables and survival. Results KRAS mutations were found in 97/194 (50%) CRC patients. In comparison to wild type KRAS tumors, KRAS- mutated ones had shown a trend toward right-sided tumors (30% and 4.3% vs 16% and 1.1%, p-value = 0.032, respectively) and peritoneal metastases (34% vs 19%, p-value = 0.014). Older age at diagnosis, gender, tumor grade, microsatellite instability (MSI), tumor stage (T), and the presence of distant metastasis were independent prognostic factors for poor overall survival (OS). There was no significant association between KRAS mutations and the hazard of mortality (HR: 0.653, 95% CI 0.873-1.134, p = 0.131). For progression-free survival (PFS), older age at presentation, MSI, tumor nodal stage (N), the presence of liver and lung metastasis, and recurrence were poor prognostic factors for PFS. There was no significant relation between KRAS mutations and PFS (HR ratio: 0.756, 95% CI 0.229-2.497, p = 0.646). Conclusions The prevalence of KRAS mutations in CRC patients was similar to that observed in previous studies of Saudi patients. KRAS mutations showed a trend toward right-sided tumors and peritoneal metastases. Survival was significantly related to different clinicopathologic variables of the study cohort but was not affected by the KRAS mutational status. Cureus 2022-03-30 /pmc/articles/PMC9053648/ /pubmed/35505757 http://dx.doi.org/10.7759/cureus.23656 Text en Copyright © 2022, Alghamdi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Alghamdi, Mohammed
Alabdullatif, Nujud
Al-Rashoud, Ajeed
Alotaibi, Joud
Alhussaini, Nouf
Elsirawani, Sedra
Somily, Haneen
Alkhudair, Norah
AlOtaiby, Maram
Ahamed, Shaik S
Abd El-Aziz, Nashwa
KRAS Mutations in Colorectal Cancer: Relationship With Clinicopathological Characteristics and Impact on Clinical Outcomes in Saudi Arabia
title KRAS Mutations in Colorectal Cancer: Relationship With Clinicopathological Characteristics and Impact on Clinical Outcomes in Saudi Arabia
title_full KRAS Mutations in Colorectal Cancer: Relationship With Clinicopathological Characteristics and Impact on Clinical Outcomes in Saudi Arabia
title_fullStr KRAS Mutations in Colorectal Cancer: Relationship With Clinicopathological Characteristics and Impact on Clinical Outcomes in Saudi Arabia
title_full_unstemmed KRAS Mutations in Colorectal Cancer: Relationship With Clinicopathological Characteristics and Impact on Clinical Outcomes in Saudi Arabia
title_short KRAS Mutations in Colorectal Cancer: Relationship With Clinicopathological Characteristics and Impact on Clinical Outcomes in Saudi Arabia
title_sort kras mutations in colorectal cancer: relationship with clinicopathological characteristics and impact on clinical outcomes in saudi arabia
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053648/
https://www.ncbi.nlm.nih.gov/pubmed/35505757
http://dx.doi.org/10.7759/cureus.23656
work_keys_str_mv AT alghamdimohammed krasmutationsincolorectalcancerrelationshipwithclinicopathologicalcharacteristicsandimpactonclinicaloutcomesinsaudiarabia
AT alabdullatifnujud krasmutationsincolorectalcancerrelationshipwithclinicopathologicalcharacteristicsandimpactonclinicaloutcomesinsaudiarabia
AT alrashoudajeed krasmutationsincolorectalcancerrelationshipwithclinicopathologicalcharacteristicsandimpactonclinicaloutcomesinsaudiarabia
AT alotaibijoud krasmutationsincolorectalcancerrelationshipwithclinicopathologicalcharacteristicsandimpactonclinicaloutcomesinsaudiarabia
AT alhussaininouf krasmutationsincolorectalcancerrelationshipwithclinicopathologicalcharacteristicsandimpactonclinicaloutcomesinsaudiarabia
AT elsirawanisedra krasmutationsincolorectalcancerrelationshipwithclinicopathologicalcharacteristicsandimpactonclinicaloutcomesinsaudiarabia
AT somilyhaneen krasmutationsincolorectalcancerrelationshipwithclinicopathologicalcharacteristicsandimpactonclinicaloutcomesinsaudiarabia
AT alkhudairnorah krasmutationsincolorectalcancerrelationshipwithclinicopathologicalcharacteristicsandimpactonclinicaloutcomesinsaudiarabia
AT alotaibymaram krasmutationsincolorectalcancerrelationshipwithclinicopathologicalcharacteristicsandimpactonclinicaloutcomesinsaudiarabia
AT ahamedshaiks krasmutationsincolorectalcancerrelationshipwithclinicopathologicalcharacteristicsandimpactonclinicaloutcomesinsaudiarabia
AT abdelaziznashwa krasmutationsincolorectalcancerrelationshipwithclinicopathologicalcharacteristicsandimpactonclinicaloutcomesinsaudiarabia